Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T.
Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583 Doi: 10.1038/s41391-018-0068-3
Web of Science PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Renner Wilfried
Co-authors Med Uni Graz: Gruber Hans-Jürgen; Herrmann Markus; Krenn-Pilko Sabine; Langsenlehner Tanja
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Telomeres are essential for the maintenance of chromosomal integrity and telomere length has been associated with cancer risk and development. Aim of the present study was to analyze the prognostic value of leukocyte relative telomere (RTL) length in long-term prostate cancer (PCa) mortality. Blood samples of PCa patients were obtained before initiation of radiotherapy. RTL of peripheral blood leukocytes was determined by a quantitative polymerase chain reaction method in 533 patients with PCa. Main outcome was overall mortality. During a median follow-up time of 149 months, 188 (35.3%) patients died. In a univariate Cox regression analysis, RTL quartiles (longer RTL) were significantly associated with higher overall mortality (hazard ration (HR) = 1.20; 95% confidence interval (CI): 1.05-1.36; p = 0.006). In a multivariate Cox regression model including age at diagnosis, androgen deprivation therapy, and risk group (based on PSA level, GS, and T stage), RTL quartiles remained a significant predictor of higher overall mortality (HR = 1.22; 95% CI: 1.07-1.39; p = 0.003). Longer leukocyte RTL predicts higher overall mortality in patients with PCa.
Find related publications in this database (using NLM MeSH Indexing): Aged -; Biomarkers, Tumor -; Combined Modality Therapy -; Humans -; Leukocyte Count -; Male -; Middle Aged -; Neoplasm Grading -; Neoplasm Staging -; Prognosis -; Proportional Hazards Models -; Prostatic Neoplasms - diagnosis; Prostatic Neoplasms - genetics; Prostatic Neoplasms - mortality; Prostatic Neoplasms - therapy; Telomere - genetics; Telomere Homeostasis -